Kiniksa Pharmaceuticals International, plc KNSA Interest Income
Discontinued — last reported Q3 '22
Interest Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed November 3, 2022, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's interest income?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported interest income of $322K in Q3 2022.
- How has Kiniksa Pharmaceuticals International, plc's interest income changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's interest income increased by 6340.0% year-over-year, from $5K to $322K.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.